New Key Statistics Module, Z-Score and F-Score
SZSE:301201 Key Ratios
Market Cap ¥ M | 2,713.68 |
Enterprise Value ¥ M | 1,412.80 |
P/E(ttm) | 30.03 |
PE Ratio without NRI | 28.43 |
Forward PE Ratio | -- |
Price/Book | 1.21 |
Price/Sales | 6.02 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | 0.49 |
Revenue (TTM) ¥ M | 412.00 |
EPS (TTM) ¥ | 0.58 |
Beneish M-Score | -2.48 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | 2.90 |
y-y EBITDA Growth Rate % | -2.80 |
EV-to-EBIT | 14.14 |
EV-to-EBITDA | 14.14 |
PEG | 9.80 |
Shares Outstanding M | 154.71 |
Net Margin (%) | 21.79 |
Operating Margin % | 14.23 |
Pre-tax Margin (%) | 24.99 |
Quick Ratio | 9.48 |
Current Ratio | 10.23 |
ROA % (ttm) | 3.76 |
ROE % (ttm) | 4.01 |
ROIC % (ttm) | 5.82 |
Dividend Yield % | 1.12 |
Altman Z-Score | 12.67 |
SZSE:301201 Number of Guru Trades
SZSE:301201 Volume of Guru Trades
Gurus Latest Trades with SZSE:301201
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:301201 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Chengda Pharmaceuticals Co Ltd Insider Transactions
No Available Data